01 1Xellia Pharmaceuticals ApS
01 1BACITRACIN STERILE USP
01 1Denmark
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2012-12-26
Pay. Date : 2012-10-31
DMF Number : 13341
Submission : 1998-09-01
Status : Active
Type : II
20
Xellia Pharmaceuticals Aps, based in Denmark, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is BACITRACIN STERILE USP, with a corresponding US DMF Number 13341.
Remarkably, this DMF maintains an Active status since its submission on September 01, 1998, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 26, 2012, and payment made on October 31, 2012, indicating their dedication to facilitating drug approvals, Categorized as Type II
